Research / FTI / Fundamental state Inspectable configuration
State dimensions Filing 0001681459-26-000053 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
13.95% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.11% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
18.33% · OPTIONAL · VALID
Revenue growth 45th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
9.39% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
42.65% · OPTIONAL · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
19.48% · CORE · VALID
R&D intensity 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.04% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Mar 31, 2019 6/7 normalized Level 3 Jun 30, 2019 6/7 normalized Level 3 Sep 30, 2019 6/7 normalized Level 3 Dec 31, 2019 7/8 normalized Level 3 Mar 31, 2020 7/7 normalized Level 3 Jun 30, 2020 7/7 normalized Level 3 Sep 30, 2020 7/7 normalized Level 3 Dec 31, 2020 7/7 normalized Level 3 Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Sep 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 14.55%
Current 13.95%
Delta -0.59% Capex Intensity Decreased
Previous 2.17%
Current 2.11%
Delta -0.07% Cash Generation Decreased
Previous 19.83%
Current 18.33%
Delta -1.51% Growth Increased
Previous 9.01%
Current 9.39%
Delta 0.38% Inventory Pressure Decreased
Previous 44.97%
Current 42.65%
Delta -2.32% Profitability Increased
Previous 19.02%
Current 19.48%
Delta 0.46% R And D Intensity Increased
Previous 0.93%
Current 1.04%
Delta 0.11% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2026
Similarity 92%
Compared 7 dimensions
Coverage 100% Growth 10.0 · Profitability 0.0 · Capex Intensity 5.0 · Cash Generation 10.0 · R And D Intensity 15.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 0.0 Mar 31, 2025
Similarity 67%
Compared 7 dimensions
Coverage 100% Growth 10.0 · Profitability 20.0 · Capex Intensity 55.0 · Cash Generation 15.0 · R And D Intensity 55.0 · Inventory Pressure 25.0 · Balance Sheet Leverage 10.0 Dec 31, 2022
Similarity 67%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Profitability 45.0 · Capex Intensity 20.0 · Cash Generation 10.0 · R And D Intensity 65.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 15.0 Sep 30, 2025
Similarity 66%
Compared 7 dimensions
Coverage 100% Growth 20.0 · Profitability 0.0 · Capex Intensity 60.0 · Cash Generation 15.0 · R And D Intensity 60.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 5.0 Sep 30, 2024
Similarity 66%
Compared 7 dimensions
Coverage 100% Growth 30.0 · Profitability 0.0 · Capex Intensity 20.0 · Cash Generation 0.0 · R And D Intensity 80.0 · Inventory Pressure 20.0 · Balance Sheet Leverage 10.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.